Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» R&D
R&D
Pfizer won’t split into two companies, so what’s next?
Stat
Mon, 09/26/16 - 03:21 pm
Pfizer
R&D
Gilead Sciences: Another Blow to R&D Strategy
Barron's
Fri, 09/23/16 - 10:06 pm
Gilead Sciences
R&D
ulcerative colitis
GS-5745
Arena Launches Drug Discovery Incubator (ARNA)
Investopedia
Mon, 09/19/16 - 06:02 pm
Arena Pharmaceuticals
R&D
drug discovery
Beacon Discovery
Eisai launches research division in Massachusetts aimed at Alzheimer’s, I/O and autoimmune diseases
Endpoints
Thu, 09/15/16 - 09:29 am
Eisai
R&D
Massachusetts
Alzheimer's disease
autoimmune disease
Takeda will transfer 300 staffers to CRO in ongoing R&D overhaul
Endpoints
Tue, 09/13/16 - 12:56 pm
Takeda
reorganization
R&D
CROs
Neuralstem Receives $20,000,000 Strategic Investment from Tianjin Pharmaceutical Group
Yahoo
Mon, 09/12/16 - 09:32 am
Neuralstem
Tianjin Pharmaceutical
R&D
China
Circle Pharma Enters into an Agreement with Pfizer to Build Screening Library of Macrocyclic Peptides
Yahoo
Mon, 09/12/16 - 09:25 am
Circle Pharma
Pfizer
R&D
macrocyclic peptides
Arena to focus on R&D with new spinout and old candidates
Fierce Biotech
Mon, 09/5/16 - 10:12 am
Arena Pharmaceuticals
R&D
Beacon Discovery
In wake of generics deal, Teva to close New York plant
BioPharma Dive
Thu, 09/1/16 - 04:44 pm
generics
Teva Pharmaceutical
drug manufacturing
R&D
Allergan
Actavis
Medivir plans year-end split
BioPharma Dive
Thu, 09/1/16 - 09:21 am
Medivir
R&D
reorganization
Scoop: Novartis disbands its pioneering cell and gene therapy unit
Endpoints
Wed, 08/31/16 - 09:24 am
Novartis
gene therapy
cell therapy
R&D
Drug Development Is Lagging For The World's Leading Killer
Forbes
Tue, 08/30/16 - 10:03 am
R&D
cardiovascular disease
Booming Moderna is raising $600M while ramping up manufacturing and clinical studies
Endpoints
Mon, 08/29/16 - 09:10 am
Moderna Therapeutics
R&D
Pascal Soriot
Biotech Exec Miralles Describes Living In Translation
Forbes
Thu, 08/25/16 - 09:41 am
Adaptive Biotechnologies
R&D
Backed by a biotech legend, two young entrepreneurs tackle one of the Holy Grails of R&D
Endpoints
Wed, 08/24/16 - 10:58 am
R&D
startups
ALS
Lou Gehrig's disease
Amylyx
Henri Termeer
Life After Martin Shkreli -- A Conversation With Turing Pharmaceutical's R&D Head
Forbes
Wed, 08/24/16 - 10:45 am
Turing Pharmaceuticals
Martin Shkreli
R&D
Drugmakers revive R&D focus on long stagnant women's health market
Medical Marketing and Media
Tue, 08/23/16 - 10:50 am
R&D
Women's Health
innovation
Myovant Sciences
Amgen
UCB Pharma
breast cancer
Pfizer
S1 Biopharma
Ibrance
Addyi
PhRMA: US remains vaccine R&D leader
BioPharma Dive
Tue, 08/23/16 - 10:08 am
vaccines
R&D
PhRMA
Can Eleven Biotherapeutics Keep Climbing With This Roche Deal?
24/7 Wall St
Wed, 08/17/16 - 10:40 am
Eleven Biotherapeutics
Roche
EBI-031
interleukin-6
R&D
Thumbs Up/Thumbs Down: The FDA backs another R&D scheme, Kite shows its speed while Eli Lilly and Astra stumble again
Endpoints
Fri, 08/12/16 - 11:05 am
FDA
R&D
Kite Pharma
AstraZeneca
Marathon Pharma
Eli Lilly
Pages
« first
‹ previous
…
46
47
48
49
50
51
52
53
54
…
next ›
last »